WVP
BDSX icon

Worth Venture Partners’s Biodesix BDSX Stock Holding History

Worth Venture Partners’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-57,090
Closed -$2.1M – 75
2023
Q4 		$2.1M Sell
57,090
-3,028
-5% -$95.1K 1.14% 30
2023
Q3 		$1.98M Sell
60,118
-3,057
-5% -$84.9K 1.18% 28
2023
Q2 		$1.55M Sell
63,175
-4,835
-7% -$145K 0.85% 37
2023
Q1 		$2.53M Sell
68,010
-6,888
-9% -$283K 1.23% 19
2022
Q4 		$3.45M Buy
+74,898
New +$2.04M 2.03% 13

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return

Worth Venture Partners's BDSX Position: Q1 2024 in Review

Worth Venture Partners sold out of Biodesix (BDSX) in Q1 2024, closing a stake of 57,090 shares — an estimated $2.1M sold.

Worth Venture Partners first reported a position in BDSX in Q4 2022 and held it in 5 quarters. The position peaked at $3.45M in Q4 2022. 43 funds tracked by Wall St. Rank hold BDSX as of Q1 2024.

  • Worth Venture Partners reported no remaining Biodesix position as of Q1 2024 after selling out during the quarter.
  • Worth Venture Partners sold 57,090 Biodesix shares in Q1 2024, an estimated $2.1M.
  • Worth Venture Partners first reported a position in Biodesix in Q4 2022 and held it in 5 quarters.
  • Worth Venture Partners's Biodesix position peaked at $3.45M in Q4 2022.
  • 43 funds tracked by Wall St. Rank held Biodesix as of Q1 2024.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.